The first cohort of Iranian patients with hyper immunoglobulin E syndrome: A long‐term follow‐up and genetic analysis

Hyper‐IgE syndromes (HIES) are distinct diseases characterized by recurrent cutaneous and lung infections, eczema, and elevated serum IgE level.

[1]  J. Ziegler,et al.  Hematopoietic Stem Cell Transplantation as Treatment for Patients with DOCK8 Deficiency. , 2019, The journal of allergy and clinical immunology. In practice.

[2]  Q. Pan-Hammarström,et al.  Clinical implications of systematic phenotyping and exome sequencing in patients with primary antibody deficiency , 2018, Genetics in Medicine.

[3]  D. Chaussabel,et al.  A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity , 2018, Science Immunology.

[4]  M. Tavassoli,et al.  Fourth Update on the Iranian National Registry of Primary Immunodeficiencies: Integration of Molecular Diagnosis , 2018, Journal of Clinical Immunology.

[5]  Steven M. Holland,et al.  International Union of Immunological Societies: 2017 Primary Immunodeficiency Diseases Committee Report on Inborn Errors of Immunity , 2017, Journal of Clinical Immunology.

[6]  M. Afarideh,et al.  Clinical, immunologic, and genetic spectrum of 696 patients with combined immunodeficiency , 2017, The Journal of allergy and clinical immunology.

[7]  S. Holland,et al.  Gastrointestinal Manifestations of STAT3-Deficient Hyper-IgE Syndrome , 2017, Journal of Clinical Immunology.

[8]  S. Holland,et al.  Distinct mutations at the same positions of STAT3 cause either loss or gain of function. , 2016, The Journal of allergy and clinical immunology.

[9]  Jean-Michel Claverie,et al.  The human gene damage index as a gene-level approach to prioritizing exome variants , 2015, Proceedings of the National Academy of Sciences.

[10]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[11]  J. Kere,et al.  Autoimmunity, hypogammaglobulinemia, lymphoproliferation, and mycobacterial disease in patients with activating mutations in STAT3. , 2015, Blood.

[12]  R. Geha,et al.  Dedicator of cytokinesis 8-deficient patients have a breakdown in peripheral B-cell tolerance and defective regulatory T cells. , 2014, The Journal of allergy and clinical immunology.

[13]  Yanming Feng,et al.  Improved molecular diagnosis by the detection of exonic deletions with target gene capture and deep sequencing , 2014, Genetics in Medicine.

[14]  A. Wollenberg,et al.  Beneficial IFN-α treatment of tumorous herpes simplex blepharoconjunctivitis in dedicator of cytokinesis 8 deficiency. , 2014, The Journal of allergy and clinical immunology.

[15]  N. Rezaei,et al.  Primary Immunodeficiency Disorders in Iran: Update and New Insights from the Third Report of the National Registry , 2014, Journal of Clinical Immunology.

[16]  Joanne M. Smart,et al.  DOCK8 is critical for the survival and function of NKT cells. , 2013, Blood.

[17]  S. Holland,et al.  Intermediate phenotypes in patients with autosomal dominant hyper-IgE syndrome caused by somatic mosaicism. , 2013, The Journal of allergy and clinical immunology.

[18]  J. Bukac,et al.  SCORAD Reflects the Duration of Atopic Dermatitis Lesions , 2013, Indian journal of dermatology.

[19]  J. Čelakovská,et al.  Allergy to Soy in an Adolescent Suffering from Atopic Dermatitis , 2013, Indian journal of dermatology.

[20]  J. Orange,et al.  Defective actin accumulation impairs human natural killer cell function in patients with dedicator of cytokinesis 8 deficiency. , 2013, The Journal of allergy and clinical immunology.

[21]  S. Holland,et al.  An update on the hyper-IgE syndromes , 2012, Arthritis Research & Therapy.

[22]  D. Uçkan,et al.  Successful bone marrow transplantation for DOCK8 deficient hyper IgE syndrome , 2012, Pediatric transplantation.

[23]  S. Yokoyama,et al.  DOCK8 is a Cdc42 activator critical for interstitial dendritic cell migration during immune responses. , 2012, Blood.

[24]  Alessandro Plebani,et al.  Dock8 Functions as an Adaptor That Links Toll-like Receptor– Myd88 Signaling to B Cell Activation Hhs Public Access , 2022 .

[25]  O. Sanal,et al.  Additional Diverse Findings Expand the Clinical Presentation of DOCK8 Deficiency , 2012, Journal of Clinical Immunology.

[26]  S. Holland,et al.  Hyper‐IgE syndrome update , 2012, Annals of the New York Academy of Sciences.

[27]  Y. Minegishi,et al.  Molecular mechanisms of the immunological abnormalities in hyper‐IgE syndrome , 2011, Annals of the New York Academy of Sciences.

[28]  J. Cyster,et al.  DOCK8 is essential for T‐cell survival and the maintenance of CD8+ T‐cell memory , 2011, European journal of immunology.

[29]  T. Ruzicka,et al.  SCORAD 75: a new metric for assessing treatment outcomes in atopic dermatitis , 2011, Journal of the European Academy of Dermatology and Venereology : JEADV.

[30]  J. Casanova,et al.  DOCK8 deficiency impairs CD8 T cell survival and function in humans and mice , 2011, The Journal of experimental medicine.

[31]  C. Goodnow,et al.  The Essential Role of DOCK8 in Humoral Immunity , 2010, Disease markers.

[32]  H. Su.  Combined Immunodeficiency Associated with DOCK8 Mutations and Related Immunodeficiencies , 2010, Disease markers.

[33]  H. Takada,et al.  [Recent advances in the pathogenesis of hyper IgE syndrome]. , 2010, Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology.

[34]  S. Holland,et al.  Pathogenesis of Hyper IgE Syndrome , 2010, Clinical reviews in allergy & immunology.

[35]  A. Schäffer,et al.  Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome. , 2010, The Journal of allergy and clinical immunology.

[36]  T. Chatila,et al.  Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome. , 2009, The Journal of allergy and clinical immunology.

[37]  Y. Minegishi.  Hyper-IgE syndrome. , 2009, Current opinion in immunology.

[38]  F. Martiniuk,et al.  Hyperimmunoglobulin E syndrome with a novel STAT3 mutation. , 2009, Dermatology online journal.

[39]  Y. Shin,et al.  A novel mutation in the linker domain of the signal transducer and activator of transcription 3 gene, p.Lys531Glu, in hyper-IgE syndrome. , 2009, The Journal of allergy and clinical immunology.

[40]  J. Kere,et al.  Novel and recurrent STAT3 mutations in hyper-IgE syndrome patients from different ethnic groups. , 2008, Molecular immunology.

[41]  M. Leppert,et al.  Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced T(H)17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome. , 2008, Journal of Allergy and Clinical Immunology.

[42]  Bodo Grimbacher,et al.  STAT3 mutations in the hyper-IgE syndrome. , 2007, The New England journal of medicine.

[43]  H. Takada,et al.  Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome , 2007, Nature.

[44]  M. Sáez-de-Ocariz,et al.  Hyper-IgE syndrome and autoimmunity in Mexican children , 2006, Pediatric Nephrology.

[45]  Joannie D Sun,et al.  Netherton syndrome: A case report and review of the literature , 2006, International journal of dermatology.

[46]  S. Holland,et al.  Hyper IgE syndrome: review and future directions , 2005, Expert review of clinical immunology.

[47]  S. Holland,et al.  Hyper‐IgE syndromes , 2005, Immunological reviews.

[48]  C. Gelmetti,et al.  The value of SCORAD and beyond. Towards a standardized evaluation of severity? , 2004, Allergy.

[49]  L. Notarangelo,et al.  Diagnostic Criteria for Primary Immunodeficiencies , 1999 .

[50]  S. Holland,et al.  Hyper-IgE syndrome with recurrent infections--an autosomal dominant multisystem disorder. , 1999, The New England journal of medicine.

[51]  J. Schaller,et al.  Job's Syndrome. Recurrent, "cold", staphylococcal abscesses. , 1966 .

[52]  S. Geng,et al.  Hyper IgE syndrome , 2014, Indian dermatology online journal.

[53]  R. Geha,et al.  DOCK8 deficient patients have a breakdown in peripheral B cell tolerance and defective regulatory T cells , 2014 .

[54]  S. Holland,et al.  Cutaneous manifestations of DOCK8 deficiency syndrome. , 2012, Archives of dermatology.

[55]  T. Ariga.  Wiskott-Aldrich syndrome; an x-linked primary immunodeficiency disease with unique and characteristic features. , 2012, Allergology international : official journal of the Japanese Society of Allergology.

[56]  N. H. Méndez,et al.  [Hyper IgE syndrome. Opportune diagnosis and management]. , 2008, Revista alergia Mexico.

[57]  Y. Hayashi,et al.  Omenn Syndrome-Review of Several Phenotypes of Omenn Syndrome and RAG1/RAG2 Mutations in Japan. , 2006, Allergology international : official journal of the Japanese Society of Allergology.

[58]  L. Notarangelo,et al.  Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). , 1999, Clinical immunology.

[59]  R. Buckley,et al.  Extreme hyperimmunoglobulinemia E and undue susceptibility to infection. , 1972, Pediatrics.